Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The race to discover Viagra for women
The Guardian, UK
Sunday, April 25, 2010 - 11:32am
tags:
Vivus, Alista, female sexual dysfunction
Earnings Preview: BioMarin Pharmaceutical's Quarterly Results will be Reported in 5 days (BMRN)
Comtex Smartrent
Sunday, April 25, 2010 - 11:27am
tags:
Biomarin
Genzyme Takes Another Hit
Seeking Alpha
Sunday, April 25, 2010 - 11:23am
tags:
Genzyme, Cerezyme, Shire, Vpriv
Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP
PR-Canada
Saturday, April 24, 2010 - 5:02pm
tags:
Sagent Pharmaceuticals, adenosine injection, Adenoscan
Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc
PR-Canada
Saturday, April 24, 2010 - 5:00pm
tags:
Ampio Pharmaceuticals, DMI Biosciences
Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
PR-USA
Saturday, April 24, 2010 - 4:59pm
tags:
Kun Run Biotechnology
Zhuzhou Qianjin Pharmaceutical Co. 2009 net profit up 0.79 pct
Trading Markets
Saturday, April 24, 2010 - 4:57pm
tags:
Zhuzhou Qianjin Pharmaceutical
AspenBio Pharma Call Options Trading Jumps Sky High
The Market Financial
Saturday, April 24, 2010 - 4:55pm
tags:
AspenBio, Appyscore, Appendicitis
U.S. jury upholds Pfizer patent
Market Watch
Saturday, April 24, 2010 - 4:53pm
tags:
Pfizer, Protonix
Acura Pharmaceuticals And King Pharmaceuticals Provide Update On FDA Advisory Committee Meeting For Acurox(R)
Medical News Today
Saturday, April 24, 2010 - 4:44pm
tags:
Acurox, Acura Pharmaceuticals, King
Start-up’s innovative cancer test gets boost
Boston Globe
Saturday, April 24, 2010 - 4:42pm
tags:
Foundation Medicine, cancer testing
A Fortress Called Zortress? Novartis Hopes Yes
Motley Fool
Saturday, April 24, 2010 - 4:39pm
tags:
Novartis, Zortress, kidney transplant
Another Pfizer Pfailure
Motley Fool
Saturday, April 24, 2010 - 4:38pm
tags:
Pfizer, Sutent, cancer
CPEX Pharmaceuticals Advises Shareholders to Take No Action at This Time in Response to Arcadia Unsolicited Tender Offer
Yahoo/BusinessWire
Saturday, April 24, 2010 - 4:36pm
tags:
CPEX Pharmaceuticals, Arcadia
A UnitedHealth Problem for Merck
Motley Fool
Saturday, April 24, 2010 - 4:34pm
tags:
Zetia, Vytorin, Merck
Human Genome Sciences: Tests Raise Questions About New Lupus Drug
Seeking Alpha
Saturday, April 24, 2010 - 1:08pm
tags:
Human Genome Sciences, belimumab, lupus
Arcadia director boosts buyout offer for CPEX
Yahoo/AP
Saturday, April 24, 2010 - 1:07pm
tags:
Arcadia, CPEX Pharmaceuticals
MediciNova Releases Notice of Pendency and Settlement of Class Action
Yahoo/BusinessWire
Saturday, April 24, 2010 - 1:04pm
tags:
MediciNova, lawsuits
Cadence to Re-file Application
Yahoo/Zacks
Saturday, April 24, 2010 - 1:02pm
tags:
Cadence Pharmaceuticals, Ofirmev
Follow-up Safety Data Show AFREZZA Comparable to Standard Antidiabetic Therapy in Lung Function Tests
Yahoo/BusinessWire
Saturday, April 24, 2010 - 1:01pm
tags:
MannKind, Afrezza, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.